Can an Emerging AI Platform Enhance Real-Time Results for Mammography?
The combination of FDA-cleared AI software for mammography triage with a medical grade edge AI platform may allow the embedding of enhanced AI detection capability within existing mammography devices.
Could an embedded AI system within mammography devices provide enhanced images, bolster workflow efficiency, and reduce hardware upgrade costs?
MedCognetics said the combination of its CogNet AI-MT AI-powered mammography software with the medical-grade edge AI platform NVIDIA IGX Orin enables real-time processing of high-quality mammography images.
MedCognetics said the combination of CogNet AI-MT AI-powered mammography software with the medical-grade edge AI platform NVIDIA IGX Orin facilitates improved image clarity and detail as well as worklist prioritization for a significantly lower cost than hardware upgrades for mammography devices. (Images courtesy of MedCognetics.)
The combination of AI technologies reportedly facilitates improved image clarity and detail as well as worklist prioritization for a significantly lower cost than hardware upgrades for mammography devices, according to MedCognetics.
“Embedding our CogNet AI-MT software directly into mammography imaging equipment means we can enhance image quality and provide immediate cancer detection without the need for costly hardware upgrades,” said Debasish “Ron” Nag, the CEO of MedCognetics. “Using the NVIDIA IGX platform, we’re advancing medical imaging technology, making high-quality diagnostic tools more accessible to radiologists and imaging centers around the world.”
Recent Videos
Related Content
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025Article
For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
FDA Clears MRI-Based AI Segmentation of Organs at Risk During Radiation Therapy
May 2nd 2025Article
Capable of segmenting over 37 organs and structures in the head, neck and pelvis, the MR Contour DL software is currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference.
